Description
40,000 equity shares of Uravi Defence and Technology Limited listed on BSE with effect from November 27, 2025, issued through conversion of warrants on preferential basis.
Summary
BSE has listed 40,000 new equity shares of Uravi Defence and Technology Limited (Scrip Code: 543930) effective November 27, 2025. These shares were issued at Rs. 330/- per share (face value Rs. 10/- plus premium of Rs. 320/-) to non-promoters on a preferential basis pursuant to conversion of warrants. The allotment was completed on September 2, 2025, and all shares are subject to lock-in restrictions.
Key Points
- 40,000 equity shares of Rs. 10/- each listed on BSE
- Issue price: Rs. 330/- per share (Rs. 10/- face value + Rs. 320/- premium)
- Issued to non-promoters through conversion of warrants on preferential basis
- Distinctive numbers: 11360001 to 11400000
- Trading permitted from Thursday, November 27, 2025
- Shares rank pari-passu with existing equity shares
- ISIN: INE568Z01015
Regulatory Changes
No regulatory changes introduced. This is a routine listing notification for new securities.
Compliance Requirements
- Trading members should note the new securities are available for trading from November 27, 2025
- Lock-in restrictions apply to all 40,000 shares until June 8, 2026
- The shares carry the same rights and privileges as existing equity shares
Important Dates
- Allotment Date: September 2, 2025
- Trading Commencement: November 27, 2025
- Lock-in Period Ends: June 8, 2026
Impact Assessment
Market Impact: Minimal. The listing involves a small number of shares (40,000) representing a preferential allotment to non-promoters. The lock-in period until June 2026 means these shares cannot be freely traded immediately, limiting any potential market impact.
Operational Impact: Routine listing process with no special operational requirements for market participants beyond noting the availability of new securities for trading from the specified date.
Impact Justification
Routine new securities listing with small issue size (40,000 shares) on preferential basis; minimal market impact due to lock-in period until June 2026